Stockreport

The Excruciating Failure That Could Cause Theravance, Down 27%, To Sell Itself [Yahoo! Finance]

Theravance Biopharma, Inc. - Ordinary Shares  (TBPH) 
Last theravance biopharma, inc. - ordinary shares earnings: 2/24 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.theravance.com/investor-relations
PDF Theravance Biopharma said it could be for sale Tuesday after its Phase 3 effort to treat a rare disease flopped. The biotech stock crashed. [Read more]